Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2005 Jun;27(6):1051-6.
doi: 10.1016/j.ejcts.2005.02.014. Epub 2005 Mar 23.

Preoperative statin use and in-hospital outcomes following heart surgery in patients with unstable angina

Imtiaz S Ali  1 , Karen J Buth
Affiliations
Comparative Study

Preoperative statin use and in-hospital outcomes following heart surgery in patients with unstable angina

Imtiaz S Ali et al. Eur J Cardiothorac Surg. 2005 Jun.

Abstract

Objective: Unstable angina (UA) is characterized by a state of coronary artery vascular inflammation and endothelial dysfunction. Statins mitigate inflammation and endothelial dysfunction and decrease mortality associated with percutaneous interventions for UA. We determined whether preoperative statin use is associated with decreased mortality and morbidity following coronary artery bypass+/-valve surgery for UA.

Methods: Patients with CCS Class IV angina having CABG+/-valve surgery were identified (n=1706). A logistic regression model determined the association of preoperative statin use with in-hospital mortality (IHM). Propensity score analysis was used to match two sub-groups of patients (GrpI, on statins, n=534; GrpII, not on statins, n=534) on factors known to affect outcomes. Outcomes were IHM, intra-aortic balloon pump (IABP) use, perioperative myocardial infarction (PMI), prolonged (>24 h) ventilation (p-vent), stroke, and a composite outcome (comp) defined as any one or more of the above.

Results: Of the 1706 patients, 1075 were on statins and 631 were not. Patients on statins were more likely to have isolated CABG, EF>40%, and be on a beta-blocker (P=0.0001); and less likely to have renal failure, MI<7 days, CHF, and undergoing urgent/emergent surgery (P=0.0001). Unadjusted rates of IHM (9 vs. 5%, P=0.001), stroke (4.4 vs. 2.3%, P=0.015), p-vent (28.4 vs. 19%, P=0.0001), and comp (32.5 vs. 22.8%, P=0.0001) were lower in patients receiving statins. After adjustment, statin use was not associated with a reduction in IHM (OR=1.0, 95% CI=0.6-1.5, P=0.85) or comp (OR=1.1, 95% CI=0.8-1.4, P=0.69). No significant differences were found in any of the propensity-adjusted outcomes for GrpI vs. GrpII: IHM (7.1 vs. 6.4%), PMI (2.8 vs. 1.7%), IABP use (3 vs. 3.8%), stroke (3.8 vs. 3.9%), p-vent (26.4 vs. 23.8%), comp (31.5 vs. 27.5%).

Conclusions: Preoperative statin use is not associated with a reduction in IHM or major morbidity following CABG+/-valve surgery in patients with UA.

PubMed Disclaimer

Comment in

  • Anaemia is a predictor of mortality in patients undergoing aortic valve surgery.
    Balta S, Demirkol S, Cakar M, Sarlak H. Balta S, et al. Eur J Cardiothorac Surg. 2014 Jan;45(1):205-6. doi: 10.1093/ejcts/ezt296. Epub 2013 May 31. Eur J Cardiothorac Surg. 2014. PMID: 23729750 No abstract available.
  • Reply to Balta et al.
    Elmistekawy E, Boodhwani M. Elmistekawy E, et al. Eur J Cardiothorac Surg. 2014 Jan;45(1):206. doi: 10.1093/ejcts/ezt297. Epub 2013 Jun 7. Eur J Cardiothorac Surg. 2014. PMID: 23749843 No abstract available.

Publication types

MeSH terms

Substances